Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2006 September;52(3) > Minerva Gastroenterologica e Dietologica 2006 September;52(3):269-74

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  A CLINICAL UPDATE IN GASTROESOPHAGEAL REFLUX DISEASE


Minerva Gastroenterologica e Dietologica 2006 September;52(3):269-74

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Extraesophageal manifestations in gastroesophageal reflux disease

Jaspersen D.

Division of Gastroenterology Academic Teaching Hospital University of Marburg, Marburg, Germany


PDF  


Gastroesophageal reflux disease (GERD) is a common condition that affects about 20-30% of the adult population, presenting with a broad spectrum of symptoms and varying degrees of severity and frequency. Other manifestations are being increasingly recognized: the so-called “extraesophageal” manifestations, such as laryngitis, hoarseness, chronic cough, asthma, or non-cardiac chest pain. Epidemiological studies consistently demonstrate significant associations between pulmonary manifestations and GERD. Up to 50% of patients with an endoscopically proven esophagitis suffer from symptoms other than heartburn or acid regurgitation. However, the published estimates of extraesophageal disorders in patients with GERD vary widely, which may be a result of referral bias. The most effective initial approach in suspected reflux-related extraesophageal symptoms is empiric proton pump inhibitor (PPI) therapy. However, studies demonstrated that the advantage of long-term PPI treatment over placebo could have been overestimated.

top of page

Publication History

Cite this article as

Corresponding author e-mail